AIMS/HYPOTHESIS: Central obesity, insulin resistance and beta cell dysfunction are independent risk factors for incident type 2 diabetes, although few studies have used detailed measures of these disorders. Our objective was to study the association of directly measured visceral and subcutaneous adipose tissue (VAT, SAT), insulin sensitivity (S (I)) and the acute insulin response (AIR) with incident type 2 diabetes. METHODS: Participants were 1,230 Hispanic-Americans and African-Americans in the Insulin Resistance Atherosclerosis Study (IRAS) Family Study who were free of type 2 diabetes at baseline (2000-2002). S (I) and AIR were determined from frequently sampled IVGTTs with minimal model analysis. VAT and SAT were determined by computed tomography. Impaired fasting glucose and type 2 diabetes were defined according to American Diabetes Association criteria. RESULTS: Incident type 2 diabetes was diagnosed in 90 participants after 5 years. After adjustment for age, sex, ethnicity, centre, impaired fasting glucose, triacylglycerol, HDL-cholesterol and systolic BP, both S(I) and AIR were inversely associated with type 2 diabetes (S (I), OR 0.53, 95% CI 0.39-0.73; AIR, OR 0.22, 95% CI 0.14-0.34 per SD; both p < 0.001), while both VAT and SAT were positively associated with type 2 diabetes (VAT, OR 1.68, 95% CI 1.22-2.33; SAT, OR 1.49, 95% CI 1.13-1.99; both p < 0.01). In a model including all four factors, S (I) and AIR (S (I), OR 0.55, 95% CI 0.37-0.80; AIR, OR 0.21, 95% CI 0.13-0.33; both p < 0.01) were significant predictors of type 2 diabetes, although associations with VAT and SAT were no longer significant. A significant sex x VAT interaction indicated a stronger association of VAT with type 2 diabetes in women than in men. CONCLUSIONS/ INTERPRETATION: Insulin resistance, beta cell dysfunction and VAT predicted incident type 2 diabetes, with evidence of a stronger association of VAT with type 2 diabetes among women.
AIMS/HYPOTHESIS: Central obesity, insulin resistance and beta cell dysfunction are independent risk factors for incident type 2 diabetes, although few studies have used detailed measures of these disorders. Our objective was to study the association of directly measured visceral and subcutaneous adipose tissue (VAT, SAT), insulin sensitivity (S (I)) and the acute insulin response (AIR) with incident type 2 diabetes. METHODS:Participants were 1,230 Hispanic-Americans and African-Americans in the Insulin Resistance Atherosclerosis Study (IRAS) Family Study who were free of type 2 diabetes at baseline (2000-2002). S (I) and AIR were determined from frequently sampled IVGTTs with minimal model analysis. VAT and SAT were determined by computed tomography. Impaired fasting glucose and type 2 diabetes were defined according to American Diabetes Association criteria. RESULTS: Incident type 2 diabetes was diagnosed in 90 participants after 5 years. After adjustment for age, sex, ethnicity, centre, impaired fasting glucose, triacylglycerol, HDL-cholesterol and systolic BP, both S(I) and AIR were inversely associated with type 2 diabetes (S (I), OR 0.53, 95% CI 0.39-0.73; AIR, OR 0.22, 95% CI 0.14-0.34 per SD; both p < 0.001), while both VAT and SAT were positively associated with type 2 diabetes (VAT, OR 1.68, 95% CI 1.22-2.33; SAT, OR 1.49, 95% CI 1.13-1.99; both p < 0.01). In a model including all four factors, S (I) and AIR (S (I), OR 0.55, 95% CI 0.37-0.80; AIR, OR 0.21, 95% CI 0.13-0.33; both p < 0.01) were significant predictors of type 2 diabetes, although associations with VAT and SAT were no longer significant. A significant sex x VAT interaction indicated a stronger association of VAT with type 2 diabetes in women than in men. CONCLUSIONS/ INTERPRETATION:Insulin resistance, beta cell dysfunction and VAT predicted incident type 2 diabetes, with evidence of a stronger association of VAT with type 2 diabetes among women.
Authors: Leora Henkin; Richard N Bergman; Donald W Bowden; Darrell L Ellsworth; Steven M Haffner; Carl D Langefeld; Braxton D Mitchell; Jill M Norris; Marian Rewers; Mohammed F Saad; Elizabeth Stamm; Lynne E Wagenknecht; Stephen S Rich Journal: Ann Epidemiol Date: 2003-04 Impact factor: 3.797
Authors: Anthony J G Hanley; Ralph D'Agostino; Lynne E Wagenknecht; Mohammed F Saad; Peter J Savage; Richard Bergman; Steven M Haffner Journal: Diabetes Date: 2002-04 Impact factor: 9.461
Authors: A R Folsom; L H Kushi; K E Anderson; P J Mink; J E Olson; C P Hong; T A Sellers; D Lazovich; R J Prineas Journal: Arch Intern Med Date: 2000-07-24
Authors: Tomoshige Hayashi; Edward J Boyko; Donna L Leonetti; Marguerite J McNeely; Laura Newell-Morris; Steven E Kahn; Wilfred Y Fujimoto Journal: Diabetes Care Date: 2003-03 Impact factor: 19.112
Authors: Lynne E Wagenknecht; Carl D Langefeld; Ann L Scherzinger; Jill M Norris; Steven M Haffner; Mohammed F Saad; Richard N Bergman Journal: Diabetes Date: 2003-10 Impact factor: 9.461
Authors: Barbara J Nicklas; Brenda W J H Penninx; Matteo Cesari; Stephen B Kritchevsky; Anne B Newman; Alka M Kanaya; Marco Pahor; Ding Jingzhong; Tamara B Harris Journal: Am J Epidemiol Date: 2004-10-15 Impact factor: 4.897
Authors: Tatiana Helfenstein; Francisco A Fonseca; Sílvia S Ihara; Juliana M Bottós; Flávio T Moreira; Henrique Pott; Michel E Farah; Maria C Martins; Maria C Izar Journal: Int J Exp Pathol Date: 2011-02 Impact factor: 1.925
Authors: Ting Yang; Xiang Gao; Monica Sandberg; Christa Zollbrecht; Xing-Mei Zhang; Michael Hezel; Ming Liu; Maria Peleli; En-Yin Lai; Robert A Harris; A Erik G Persson; Bertil B Fredholm; Leif Jansson; Mattias Carlström Journal: Diabetologia Date: 2015-04-03 Impact factor: 10.122
Authors: E Ferrannini; A Natali; E Muscelli; P M Nilsson; A Golay; M Laakso; H Beck-Nielsen; A Mari Journal: Diabetologia Date: 2011-03-22 Impact factor: 10.122
Authors: Kendra A Young; Amita Maturu; Carlos Lorenzo; Carl D Langefeld; Lynne E Wagenknecht; Yii-Der I Chen; Kent D Taylor; Jerome I Rotter; Jill M Norris; Neda Rasouli Journal: J Diabetes Complications Date: 2018-11-03 Impact factor: 2.852
Authors: Nana Gletsu-Miller; Henry S Kahn; Danijela Gasevic; Zhe Liang; Jennifer K Frediani; William E Torres; Thomas R Ziegler; Lawrence S Phillips; Edward Lin Journal: Obes Surg Date: 2013-07 Impact factor: 4.129